Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

MANEESH PHARMACEUTICALS LIMITED

Active

MANEESH PHARMACEUTICALS LIMITED having CIN U24230MH1985PLC036952 is 39 years , 10 month & 13 days old Public Indian Company incorporated on 25 Jul 1985. It is classified as Non-government company and is registered at ROC Mumbai. Its authorized share capital is Rs. 300,000,000 and its paid up capital is Rs. 281,251,870. It's NIC code is 24230 (which is part of its CIN).

As per the NIC code, it is involved in . MANEESH PHARMACEUTICALS LIMITED Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 07-11-2023. Directors of MANEESH PHARMACEUTICALS LIMITED are Rakesh Khetan Tunaram and Vinay Ramakant Sapte.

MANEESH PHARMACEUTICALS LIMITED ' Corporate Identification Number (CIN) is U24230MH1985PLC036952 and its registration number is 036952. Users may contact MANEESH PHARMACEUTICALS LIMITED on its Email address - cs@maneeshpharma.com Registered address of MANEESH PHARMACEUTICALS LIMITED is 29/33 , Ancillary Industrial Plots, Govandi,Mumbai,Maharashtra,India-400043. Current status of MANEESH PHARMACEUTICALS LIMITED is - Active.

Key Indicators

Authorised Capital
300,000,000

as on 07/06/2025

Paid Up Capital
281,251,870

as on 07/06/2025

Company Age
39 Year, 10 Months
Last Filing with ROC
1 Year, 10 Months

Company Information

CIN U24230MH1985PLC036952
Company Status Active
Registration Number 036952
Date of Incorporation 07/25/1985
RoC ROC Mumbai
Company Age 39 years & 327 days
Authorized Capital ₹ 300000000
Paid-up capital ₹ 281251870
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Public
Activity
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2023
Date of Latest Balance Sheet 31-03-2021

Contact

Email ID cs@maneeshpharma.com
Address 29/33, Ancillary Industrial Plots, Govandi Mumbai Maharashtra India 400043
Website maneeshpharma.com
Contact Number +91*******

Location on Map

Director

Designation Name Date OF Appointment DIN PAN Tenure
Director 01/01/1900 ADIPA2886M *****8732F 125 years
Director 03/14/2023 00334247 2 years
Director 05/25/2023 00135085 *****6169H 2 years
Director 05/04/2017 01404954 *****2938Q 8 years
Director 01/27/2023 00020450 2 years
Director 09/18/2018 08196191 *****2845E 6 years
Director 10/31/2019 00081012 *****7583C 5 years
Director 03/20/2015 00458763 *****7841F 10 years

Companies connected through Directors

Name Status Paid Up Capital Common Directors Address
Active
1,00,000.00 2 Maharashtra
Active
2,80,00,000.00 2 Maharashtra
Active
45,45,200.00 2
Converted to LLP
1,00,000.00 2 Maharashtra
Converted to LLP
99,24,000.00 2 Maharashtra
Active
1,00,000.00 2 Maharashtra
Amalgamated
1,00,000.00 2 Maharashtra
Converted to LLP
3,76,300.00 2 Maharashtra
Active
1,62,500.00 1 Maharashtra
Active
1,13,25,50,020.00 1 Maharashtra
Active
17,48,64,180.00 1 Maharashtra
Strike Off
1,00,000.00 1 Maharashtra
Strike Off
1,00,000.00 1 Maharashtra
Strike Off
1,00,000.00 1 Maharashtra
Amalgamated
55,00,000.00 1 Maharashtra
Active
26,00,000.00 1 Maharashtra
Active
25,06,45,45,450.00 1 Gujarat
Active
5,85,51,18,250.00 1 Tamil Nadu
Active
4,80,00,000.00 1 Maharashtra
Amalgamated
55,00,000.00 1 Maharashtra
Active
7,32,11,81,830.00 1 Maharashtra
Strike Off
50,00,000.00 1 Maharashtra
Active
3,28,29,720.00 1 Maharashtra
Strike Off
1,00,000.00 1 Maharashtra
Amalgamated
20,00,000.00 1 Maharashtra
Strike Off
5,00,000.00 1 Maharashtra
Active
13,99,17,540.00 3 Maharashtra

Charges on assets

1

Others

No. of Loans: 1

Total Amount: 200,000,000.00 cr

2

IL & FS TRUST COMPANY LIMITED

No. of Loans: 1

Total Amount: 1,788,300,000.00 cr

3

ALCHEMIST ASSET RECONSTRUCTION COMPANY LIMITED

No. of Loans: 1

Total Amount: 215,000,000.00 cr

4

ICICI BANK LIMITED

No. of Loans: 8

Total Amount: 2,671,930,000.00 cr

5

KOTAK MAHINDRA BANK LTD

No. of Loans: 1

Total Amount: 100,000,000.00 cr

6

HDFC BANK LIMITED

No. of Loans: 1

Total Amount: 100,000,000.00 cr

7

Adhrit Education Private Limited

No. of Loans: 1

Total Amount: 182,500,000.00 cr

8

Vijaya Bank

No. of Loans: 1

Total Amount: 18,800,000.00 cr

9

Citi Bank N.A.

No. of Loans: 4

Total Amount: 1,250,000,000.00 cr

10

CORPORATION BANK

No. of Loans: 1

Total Amount: 9,000,000.00 cr

11

Standard Chartered Bank

No. of Loans: 1

Total Amount: 126,000,000.00 cr

12

Bank of Bahrain & Kuwait B.S.C.

No. of Loans: 1

Total Amount: 45,344,000.00 cr

13

Pegasus Group Twenty Six Trust - I- Pegasus Assets Reconstruction Private Limited

No. of Loans: 3

Total Amount: 1,845,800,000.00 cr

14

3i Infotech Trusteeship Services Limited

No. of Loans: 5

Total Amount: 1,235,000,000.00 cr

15

ABN Amro Bank N.V.

No. of Loans: 1

Total Amount: 450,000,000.00 cr

16

BOMBAY MERCANTILE BANK LTD.

No. of Loans: 1

Total Amount: 13,000,000.00 cr

17

BOMBAY MERCANTILE CO-OPERATIVE BANK LTD

No. of Loans: 1

Total Amount: 37,500,000.00 cr

18

BOMBAY MERCANTILE CO-OP BANK LTD

No. of Loans: 1

Total Amount: 7,245,000.00 cr

19

KOTAK MAHINDRA BANK LIMITED

No. of Loans: 1

Total Amount: 158,900,000.00 cr

20

Export-Import Bank Of India

No. of Loans: 1

Total Amount: 180,000,000.00 cr

Charge Holder Branch Amount Date of creation Modification Satisfaction Status
Others 200,000,000 13 Dec, 2007 30 Jun, 2014 12 Jul, 2022 Closed
IL & FS TRUST COMPANY LIMITED KURLA COMPLEX BANDRA EAST 1,788,300,000 03 Jun, 2008 26 Mar, 2010 14 Jul, 2022 Closed
ALCHEMIST ASSET RECONSTRUCTION COMPANY LIMITED 215,000,000 15 Nov, 2000 29 Oct, 2013 12 Jul, 2022 Closed
ICICI BANK LIMITED ALKAPURI 206,930,000 06 Jul, 2006 05 Sep, 2008 27 Oct, 2015 Closed
KOTAK MAHINDRA BANK LTD W.E.F.29.01.2001 100,000,000 22 Jan, 2007 - 27 Jun, 2012 Closed
ICICI BANK LIMITED ALKAPURI 500,000,000 14 Mar, 2007 - 30 Oct, 2015 Closed
ICICI BANK LIMITED ALKAPURI 500,000,000 14 Mar, 2007 - 15 Oct, 2015 Closed
HDFC BANK LIMITED LOWER PAREL W 100,000,000 28 Mar, 2007 - 01 Sep, 2009 Closed
ICICI BANK LIMITED ALKAPURI 500,000,000 16 Mar, 2007 - 27 Oct, 2015 Closed
Adhrit Education Private Limited Matunga Central 182,500,000 11 Sep, 2006 30 Apr, 2013 01 Sep, 2015 Closed
ICICI BANK LIMITED ALKAPURI 180,000,000 17 Oct, 2006 - 27 Mar, 2008 Closed
ICICI BANK LIMITED ALKAPURI 420,000,000 23 Dec, 2006 - 15 Oct, 2015 Closed
ICICI BANK LIMITED ALKAPURI 180,000,000 19 Oct, 2006 - 27 Mar, 2008 Closed
Vijaya Bank S V ROAD, 18,800,000 28 Mar, 2005 25 Aug, 2008 25 Jul, 2014 Closed
Citi Bank N.A. 2ND FLOOR, BANDRA KURLA COMPLEX, BANDRA (E) 150,000,000 07 Jun, 2006 - 08 Nov, 2013 Closed
Citi Bank N.A. 2ND FLOOR, BANDRA KURLA COMPLEX, BANDRA (E) 150,000,000 07 Jun, 2006 - 08 Nov, 2013 Closed
CORPORATION BANK 9,000,000 25 Feb, 2004 - 11 Mar, 2016 Closed
Standard Chartered Bank Fort, 126,000,000 14 Jun, 2004 - 24 Jan, 2017 Closed
Bank of Bahrain & Kuwait B.S.C. Nariman Point, 45,344,000 21 Mar, 2005 - 28 Feb, 2007 Closed
Pegasus Group Twenty Six Trust - I- Pegasus Assets Reconstruction Private Limited Nariman Point 640,000,000 23 Apr, 2005 13 Jun, 2014 09 Oct, 2015 Closed
3i Infotech Trusteeship Services Limited Tower No.5, Vashi Railway Station Complex, Vashi 250,000,000 11 Oct, 2008 - 27 Oct, 2015 Closed
ABN Amro Bank N.V. Nariman Point 450,000,000 23 Apr, 2008 - 29 Dec, 2015 Closed
3i Infotech Trusteeship Services Limited Tower No.5, Vashi Railway Station Complex, Vashi 400,000,000 09 Apr, 2008 - 04 Nov, 2015 Closed
3i Infotech Trusteeship Services Limited Tower No.5, Vashi Railway Station Complex, Vashi 185,000,000 11 Jan, 2008 - 30 Oct, 2015 Closed
Pegasus Group Twenty Six Trust - I- Pegasus Assets Reconstruction Private Limited Nariman Point 100,000,000 05 Mar, 2010 13 Jun, 2014 09 Oct, 2015 Closed
ICICI BANK LIMITED ALKAPURI 185,000,000 18 Feb, 2011 08 Jun, 2011 27 Oct, 2015 Closed
Pegasus Group Twenty Six Trust - I- Pegasus Assets Reconstruction Private Limited Nariman Point 1,105,800,000 28 Dec, 2011 13 Jun, 2014 09 Oct, 2015 Closed
Citi Bank N.A. BANDRA KURLA COMPLEX, BANDRA (EAST) 150,000,000 24 Nov, 2006 - 08 Nov, 2013 Closed
BOMBAY MERCANTILE BANK LTD. MAHIM 13,000,000 30 Jan, 2006 - 08 Dec, 2007 Closed
BOMBAY MERCANTILE CO-OPERATIVE BANK LTD 37,500,000 12 Jan, 2008 - 09 May, 2014 Closed
3i Infotech Trusteeship Services Limited Tower No.5, Vashi Railway Station Complex, Vashi 200,000,000 26 Jul, 2008 - 04 Nov, 2015 Closed
Citi Bank N.A. BANDRA KURLA COMPLEX, BANDRA (E) 800,000,000 30 May, 2008 15 Mar, 2010 29 Oct, 2013 Closed
BOMBAY MERCANTILE CO-OP BANK LTD MAHIM, 7,245,000 04 Aug, 2006 - 06 Apr, 2009 Closed
KOTAK MAHINDRA BANK LIMITED NARIMAN POINT, 158,900,000 29 Mar, 2006 16 Mar, 2009 27 Jun, 2012 Closed
Export-Import Bank Of India Cuffe Parade 180,000,000 19 Jul, 2004 - - Open
3i Infotech Trusteeship Services Limited Tower No.5, Vashi Railway Station Complex, Vashi 200,000,000 25 Jul, 2008 - 04 Nov, 2015 Closed

Registered Details

CIN
U24230MH1985PLC036952
PAN
U24230MH1985PLC036952
Incorporation
10 years , 2 month
Company Email
cs@maneeshpharma.com
Paid up Capital
₹ 281,251,870
Authorised Capital
₹ 300,000,000
Type
Public Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales arrow 9.29%
₹ 140,987.4
EBITDA arrow 29%
₹ 135,987.4
Net Profit arrow 29%
₹ 135,987.4
Networth arrow 29%
₹ 135,987.4
Borrowings arrow 9.29%
₹ 140,987.4
Assets arrow 9.29%
₹ 140,987.4
Gross Margin arrow 9.29%
₹ 140,987.4
Operating Margin arrow 29%
₹ 135,987.4
Net Profit Margin arrow 29%
₹ 135,987.4
Return on Equity arrow 29%
₹ 135,987.4
ROCE arrow 9.29%
₹ 140,987.4
Debt to Equity arrow 9.29%
₹ 140,987.4

Financial Highlights

** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales Locked Locked Locked Locked Locked
Operating profit Locked Locked Locked Locked Locked
Net profit Locked Locked Locked Locked Locked
Gross margin Locked Locked Locked Locked Locked
Operating margin Locked Locked Locked Locked Locked
Net margin Locked Locked Locked Locked Locked
Networth Locked Locked Locked Locked Locked
Borrowings Locked Locked Locked Locked Locked
Assets Locked Locked Locked Locked Locked
Debt to equity Locked Locked Locked Locked Locked
Current ratio Locked Locked Locked Locked Locked
ROE Locked Locked Locked Locked Locked
Days payable Locked Locked Locked Locked Locked
WC days Locked Locked Locked Locked Locked
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + Locked Locked Locked Locked Locked
(a) Share capita Locked Locked Locked Locked Locked
(b) Reserves and surplus Locked Locked Locked Locked Locked
(c) Money received against share warrants Locked Locked Locked Locked Locked
(2) Share application money pending allotment Locked Locked Locked Locked Locked
(3) Non-current liabilities + Locked Locked Locked Locked Locked
(a) Long-term borrowings Locked Locked Locked Locked Locked
(b) Deferred tax liabilities (Net) Locked Locked Locked Locked Locked
(c) Other Long-term liabilities Locked Locked Locked Locked Locked
(d) Long-term provisions Locked Locked Locked Locked Locked
(4) Current liabilities + Locked Locked Locked Locked Locked
(a) Short-term borrowings Locked Locked Locked Locked Locked
(b) Trade payables Locked Locked Locked Locked Locked
(A) total outstanding dues of micro enterprises and small enterprises; and Locked Locked Locked Locked Locked
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. Locked Locked Locked Locked Locked
(c) Other current liabilities Locked Locked Locked Locked Locked
(d) Short-term provisions Locked Locked Locked Locked Locked
Total Locked Locked Locked Locked Locked
ASSETS
Non-current assets + Locked Locked Locked Locked Locked
(a) [Property, Plant and Equipment] Locked Locked Locked Locked Locked
(i) Tangible assets Locked Locked Locked Locked Locked
(ii) Intangible assets Locked Locked Locked Locked Locked
(iii)Capital work-in-progress Locked Locked Locked Locked Locked
(iv) Intangible assets under development Locked Locked Locked Locked Locked
(b) Non-current investments Locked Locked Locked Locked Locked
(c) Deferred tax assets (net) Locked Locked Locked Locked Locked
(d) Long-term loans and advances Locked Locked Locked Locked Locked
(e) Other non-current assets Locked Locked Locked Locked Locked
(2) Current assets + Locked Locked Locked Locked Locked
(a) Current investments Locked Locked Locked Locked Locked
(b) Inventories Locked Locked Locked Locked Locked
(c) Trade receivables Locked Locked Locked Locked Locked
(d) Cash and cash equivalents Locked Locked Locked Locked Locked
(e) Short-term loans and advances Locked Locked Locked Locked Locked
(f) Other current assets Locked Locked Locked Locked Locked
Total assets Locked Locked Locked Locked Locked
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + lock lock lock lock lock
(a) Share capita lock lock lock lock lock
(b) Reserves and surplus lock lock lock lock lock
(c) Money received against share warrants lock lock lock lock lock
(2) Share application money pending allotment lock lock lock lock lock
(3) Non-current liabilities + lock lock lock lock lock
(a) Long-term borrowings lock lock lock lock lock
(b) Deferred tax liabilities (Net) lock lock lock lock lock
(c) Other Long-term liabilities lock lock lock lock lock
(d) Long-term provisions lock lock lock lock lock
(4) Current liabilities + lock lock lock lock lock
(a) Short-term borrowings lock lock lock lock lock
(b) Trade payables lock lock lock lock lock
(A) total outstanding dues of micro enterprises and small enterprises; and lock lock lock lock lock
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. lock lock lock lock lock
(c) Other current liabilities lock lock lock lock lock
(d) Short-term provisions lock lock lock lock lock
Total lock lock lock lock lock
ASSETS
Non-current assets + lock lock lock lock lock
(a) [Property, Plant and Equipment] lock lock lock lock lock
(i) Tangible assets lock lock lock lock lock
(ii) Intangible assets lock lock lock lock lock
(iii)Capital work-in-progress lock lock lock lock lock
(iv) Intangible assets under development lock lock lock lock lock
(b) Non-current investments lock lock lock lock lock
(c) Deferred tax assets (net) lock lock lock lock lock
(d) Long-term loans and advances lock lock lock lock lock
(e) Other non-current assets lock lock lock lock lock
(2) Current assets + lock lock lock lock lock
(a) Current investments lock lock lock lock lock
(b) Inventories lock lock lock lock lock
(c) Trade receivables lock lock lock lock lock
(d) Cash and cash equivalents lock lock lock lock lock
(e) Short-term loans and advances lock lock lock lock lock
(f) Other current assets lock lock lock lock lock
Total assets lock lock lock lock lock

Profit & Loss

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
I.Revenue from operations lock lock lock lock lock
II. Other income lock lock lock lock lock
III.Total Revenue (I + II) lock lock lock lock lock
IV.Expenses + lock lock lock lock lock
(1)Cost of materials consumed lock lock lock lock lock
(2)Purchases of Stock-in-Trade lock lock lock lock lock
(3)Changes in inventories of finished goods work-in-progress and lock lock lock lock lock
(4)Stock-in-Trade lock lock lock lock lock
(5)Employee benefits expense lock lock lock lock lock
(6)Finance costs lock lock lock lock lock
(7)Depreciation and amortisation expense lock lock lock lock lock
(8)Other expenses lock lock lock lock lock
(9)Total expenses lock lock lock lock lock
VProfit before exceptional and extraordinary items and tax (III - IV) lock lock lock lock lock
VIExceptional items lock lock lock lock lock
VII.Profit before extraordinary items and tax (V - VI) lock lock lock lock lock
VIII.Extraordinary items lock lock lock lock lock
IX.Profit before tax (VII- VIII) lock lock lock lock lock
X. Tax expense: + lock lock lock lock lock
(1)Current tax lock lock lock lock lock
(2)Deferred tax lock lock lock lock lock
XI.Profit (Loss) for the period from continuing operations (VII-VIII) lock lock lock lock lock
XII.Profit/(loss) from discontinuing operations lock lock lock lock lock
XIII.Tax expense of discontinuing operations lock lock lock lock lock
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) lock lock lock lock lock
XV.Profit (Loss) for the period (XI + XIV) lock lock lock lock lock
XVI.Earnings per equity share: + lock lock lock lock lock
(1) Basic lock lock lock lock lock
(2)Diluted lock lock lock lock lock
Precentage of total incomex
Sales +
Sales growth %
Expenses +
Cost of services
Employee benefits expense
Other costs
Operating profit + lock lock lock
Operating margin % lock lock lock
Other income
Interest lock lock lock
Depreciation lock lock lock
Exceptional items
Profit before tax
Tax lock lock lock
Profit - disc. ops lock lock lock
Net profit lock lock lock
Net margin % lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR crores

Solvency +
Total Debt/Equity
Net Debt/Equity lock lock lock
Total Debt/Assets
Total Assets/Equity
Liquidity +
Current Ratio
Quick Ratio
Interest Coverage
Performance lock lock lock
Gross Margin
Operating Margin
Net Margin
Return + lock lock lock
Return on Equity
Pre-tax ROCE lock lock lock
Return on Assets lock lock lock
Pre-tax ROIC lock lock lock
Efficiency + lock lock lock
Days Payable lock lock lock
Days Inventory lock lock lock
Days Receivable lock lock lock
Fixed Asset Turnover lock lock lock
Total Asset Turnover lock lock lock
Working Capital lock lock lock
Cash Conversion Cycle lock lock lock
Working Capital Days lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of Maneesh Pharmaceuticals Limited

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of Maneesh Pharmaceuticals Limited

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of Maneesh Pharmaceuticals Limited

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock

Auditors of Maneesh Pharmaceuticals Limited

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About Maneesh Pharmaceuticals Limited

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of Maneesh Pharmaceuticals Limited

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- Maneesh Pharmaceuticals Limited

What is MANEESH PHARMACEUTICALS LIMITED ?

MANEESH PHARMACEUTICALS LIMITED having CIN U24230MH1985PLC036952 is 10 years , 2 month old Public Indian Company incorporated with MCA on 20 Mar 2015. MANEESH PHARMACEUTICALS LIMITED is listed in the class of Public Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Mumbai with an Authorized Share Capital of 300,000,000 and paid-up capital is 281,251,870.

What is the CIN of MANEESH PHARMACEUTICALS LIMITED?

CIN of MANEESH PHARMACEUTICALS LIMITED is U24230MH1985PLC036952.

Where is MANEESH PHARMACEUTICALS LIMITED located?

Address of MANEESH PHARMACEUTICALS LIMITED is 29/33 , ancillary industrial plots, govandi,mumbai,maharashtra,india-400043,.

Who are the directors of MANEESH PHARMACEUTICALS LIMITED ?

The company has 15 directors/key management personnel . .,rashmi Sapte,vinay Sapte,pravin Hegde,maneesh Sapte,maneesh Sapte,ajit Jamkhandikar,utpal Sheth,rakesh Tunaram,sejal Jain,chetan Chandwani,u24230mh1985plc036952 U24230mh1985plc036952,rashmi Sapte,utpal Sheth,vinay Sapte,

What is the contact details of MANEESH PHARMACEUTICALS LIMITED ?

Email : cs@maneeshpharma.com
Address : 29/33, Ancillary Industrial Plots, Govandi Mumbai Maharashtra India 400043

What does MANEESH PHARMACEUTICALS LIMITED do?

MANEESH PHARMACEUTICALS LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Search

Top Companies in your State

Enquiry